-
1
-
-
80052270947
-
The epidemiology of renal cell carcinoma
-
Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, Kiemeney LA (2011) The epidemiology of renal cell carcinoma. Eur Urol 60:615-621
-
(2011)
Eur Urol
, vol.60
, pp. 615-621
-
-
Ljungberg, B.1
Campbell, S.C.2
Choi, H.Y.3
Jacqmin, D.4
Lee, J.E.5
Weikert, S.6
Kiemeney, L.A.7
-
2
-
-
0032772880
-
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
-
Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17:2530-2540
-
(1999)
J Clin Oncol
, vol.17
, pp. 2530-2540
-
-
Motzer, R.J.1
Mazumdar, M.2
Bacik, J.3
Berg, W.4
Amsterdam, A.5
Ferrara, J.6
-
3
-
-
84856159566
-
Targeted therapies for renal cell carcinoma: Review of adverse event management strategies
-
Eisen T, Sternberg CN, Robert C, Mulders P, Pyle L, Zbinden S, Izzedine H, Escudier B (2012) Targeted therapies for renal cell carcinoma: review of adverse event management strategies. J Natl Cancer Inst 104:93-113
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 93-113
-
-
Eisen, T.1
Sternberg, C.N.2
Robert, C.3
Mulders, P.4
Pyle, L.5
Zbinden, S.6
Izzedine, H.7
Escudier, B.8
-
4
-
-
33846181370
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
-
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356:115-124
-
(2007)
N Engl J Med
, vol.356
, pp. 115-124
-
-
Motzer, R.J.1
Hutson, T.E.2
Tomczak, P.3
Michaelson, M.D.4
Bukowski, R.M.5
Rixe, O.6
Oudard, S.7
Negrier, S.8
Szczylik, C.9
Kim, S.T.10
Chen, I.11
Bycott, P.W.12
Baum, C.M.13
Figlin, R.A.14
-
5
-
-
33846148701
-
Sorafenib in advanced clear-cell renal-cell carcinoma
-
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356:125-134
-
(2007)
N Engl J Med
, vol.356
, pp. 125-134
-
-
Escudier, B.1
Eisen, T.2
Stadler, W.M.3
Szczylik, C.4
Oudard, S.5
Siebels, M.6
Negrier, S.7
Chevreau, C.8
Solska, E.9
Desai, A.A.10
Rolland, F.11
Demkow, T.12
Hutson, T.E.13
Gore, M.14
Freeman, S.15
Schwartz, B.16
Shan, M.17
Simantov, R.18
Bukowski, R.M.19
-
6
-
-
0031886289
-
Induction of apoptosis in human leukemic U937 cells by tetrandrine
-
Lai YL, Chen YJ, Wu TY, Wang SY, Chang KH, Chung CH, Chen ML (1998) Induction of apoptosis in human leukemic U937 cells by tetrandrine. Anticancer Drugs 9:77-81
-
(1998)
Anticancer Drugs
, vol.9
, pp. 77-81
-
-
Lai, Y.L.1
Chen, Y.J.2
Wu, T.Y.3
Wang, S.Y.4
Chang, K.H.5
Chung, C.H.6
Chen, M.L.7
-
7
-
-
79959757676
-
Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma
-
Liu C, Gong K, Mao X, Li W (2011) Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Int J Cancer 129:1519-1531
-
(2011)
Int J Cancer
, vol.129
, pp. 1519-1531
-
-
Liu, C.1
Gong, K.2
Mao, X.3
Li, W.4
-
8
-
-
0036281314
-
Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells
-
Yoo SM, Oh SH, Lee SJ, Lee BW, Ko WG, Moon CK, Lee BH (2002) Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells. J Ethnopharmacol 81:225-229
-
(2002)
J Ethnopharmacol
, vol.81
, pp. 225-229
-
-
Yoo, S.M.1
Oh, S.H.2
Lee, S.J.3
Lee, B.W.4
Ko, W.G.5
Moon, C.K.6
Lee, B.H.7
-
9
-
-
84863131190
-
Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy"
-
Li X, Lu X, Xu H, Zhu Z, Yin H, Qian X, Li R, Jiang X, Liu B (2012) Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy". Mol Pharm 9:222-229
-
(2012)
Mol Pharm
, vol.9
, pp. 222-229
-
-
Li, X.1
Lu, X.2
Xu, H.3
Zhu, Z.4
Yin, H.5
Qian, X.6
Li, R.7
Jiang, X.8
Liu, B.9
-
10
-
-
78751559362
-
Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer
-
He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, Kim SH, Huang E, Gao Y, Yang K, Wagner ER, Wang L, Tang N, Luo J, Liu X, Li M, Bi Y, Shen J, Luther G, Hu N, Zhou Q, Luu HH, Haydon RC, Zhao Y, He TC (2011) Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79:211-219
-
(2011)
Mol Pharmacol
, vol.79
, pp. 211-219
-
-
He, B.C.1
Gao, J.L.2
Zhang, B.Q.3
Luo, Q.4
Shi, Q.5
Kim, S.H.6
Huang, E.7
Gao, Y.8
Yang, K.9
Wagner, E.R.10
Wang, L.11
Tang, N.12
Luo, J.13
Liu, X.14
Li, M.15
Bi, Y.16
Shen, J.17
Luther, G.18
Hu, N.19
Zhou, Q.20
Luu, H.H.21
Haydon, R.C.22
Zhao, Y.23
He, T.C.24
more..
-
11
-
-
72949109102
-
Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice
-
Wu JM, Chen Y, Chen JC, Lin TY, Tseng SH (2010) Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett 287:187-195
-
(2010)
Cancer Lett
, vol.287
, pp. 187-195
-
-
Wu, J.M.1
Chen, Y.2
Chen, J.C.3
Lin, T.Y.4
Tseng, S.H.5
-
12
-
-
64849099003
-
Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells
-
Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, Hwang SK, Kwon JT, Tehrani AM, Woo M, Noh MS, Hanifah H, Jin H, Xu CX, Cho MH (2009) Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci 10:23-28
-
(2009)
J Vet Sci
, vol.10
, pp. 23-28
-
-
Cho, H.S.1
Chang, S.H.2
Chung, Y.S.3
Shin, J.Y.4
Park, S.J.5
Lee, E.S.6
Hwang, S.K.7
Kwon, J.T.8
Tehrani, A.M.9
Woo, M.10
Noh, M.S.11
Hanifah, H.12
Jin, H.13
Xu, C.X.14
Cho, M.H.15
-
13
-
-
78649875624
-
The potential of tetrandrine against gliomas
-
Chen Y, Tseng SH (2010) The potential of tetrandrine against gliomas. Anticancer Agents Med Chem 10:534-542
-
(2010)
Anticancer Agents Med Chem
, vol.10
, pp. 534-542
-
-
Chen, Y.1
Tseng, S.H.2
-
14
-
-
64249171902
-
Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats
-
Chen Y, Chen JC, Tseng SH (2009) Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int J Cancer 124: 2260-2269
-
(2009)
Int J Cancer
, vol.124
, pp. 2260-2269
-
-
Chen, Y.1
Chen, J.C.2
Tseng, S.H.3
-
15
-
-
84866451273
-
Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein1
-
Wang TH, Wan JY, Gong X, Li HZ, Cheng Y (2012) Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein1. Oncol Rep 28:1681-1686
-
(2012)
Oncol Rep
, vol.28
, pp. 1681-1686
-
-
Wang, T.H.1
Wan, J.Y.2
Gong, X.3
Li, H.Z.4
Cheng, Y.5
-
16
-
-
79951680794
-
Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells
-
Li X, Su B, Liu R, Wu D, He D (2011) Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J Surg Res 166:e45-e51
-
(2011)
J Surg Res
, vol.166
-
-
Li, X.1
Su, B.2
Liu, R.3
Wu, D.4
He, D.5
-
17
-
-
0036902141
-
Potential role of tetrandrine in cancer therapy
-
Chen YJ (2002) Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin 23:1102-1106
-
(2002)
Acta Pharmacol Sin
, vol.23
, pp. 1102-1106
-
-
Chen, Y.J.1
-
18
-
-
78751525898
-
Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria
-
Zeng J, Sun Y, Wu K, Li L, Zhang G, Yang Z, Wang Z, Zhang D, Xue Y, Chen Y, Zhu G, Wang X, He D (2011) Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria. Mol Cancer Ther 10:104-116
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 104-116
-
-
Zeng, J.1
Sun, Y.2
Wu, K.3
Li, L.4
Zhang, G.5
Yang, Z.6
Wang, Z.7
Zhang, D.8
Xue, Y.9
Chen, Y.10
Zhu, G.11
Wang, X.12
He, D.13
-
19
-
-
79951831808
-
Caspase signaling in animal development
-
Kuranaga E (2011) Caspase signaling in animal development. Dev Growth Differ 53:137-148
-
(2011)
Dev Growth Differ
, vol.53
, pp. 137-148
-
-
Kuranaga, E.1
-
20
-
-
79952827283
-
Comparative nephrotoxicity of aristolochic acid and tetrandrine in vitro and in vivo
-
Yuan SY, Yang CR, Cheng CL, Hsu SL, Liao JW, Lin CC, Chou YY, Cheng YW (2011) Comparative nephrotoxicity of aristolochic acid and tetrandrine in vitro and in vivo. Int J Toxicol 30: 35-46
-
(2011)
Int J Toxicol
, vol.30
, pp. 35-46
-
-
Yuan, S.Y.1
Yang, C.R.2
Cheng, C.L.3
Hsu, S.L.4
Liao, J.W.5
Lin, C.C.6
Chou, Y.Y.7
Cheng, Y.W.8
-
21
-
-
0026643607
-
Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats
-
Lieberman I, Lentz DP, Trucco GA, Seow WK, Thong YH (1992) Prevention by tetrandrine of spontaneous development of diabetes mellitus in BB rats. Diabetes 41:616-619
-
(1992)
Diabetes
, vol.41
, pp. 616-619
-
-
Lieberman, I.1
Lentz, D.P.2
Trucco, G.A.3
Seow, W.K.4
Thong, Y.H.5
-
22
-
-
32244448778
-
Targeting apoptosis with dietary bioactive agents
-
Martin KR (2006) Targeting apoptosis with dietary bioactive agents. Exp Biol Med (Maywood) 231:117-129
-
(2006)
Exp Biol Med (Maywood)
, vol.231
, pp. 117-129
-
-
Martin, K.R.1
-
23
-
-
47949099869
-
Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis
-
Chen XL, Ren KH, He HW, Shao RG (2008) Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis. Cancer Biol Ther 7:1073-1078
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 1073-1078
-
-
Chen, X.L.1
Ren, K.H.2
He, H.W.3
Shao, R.G.4
-
24
-
-
60749109846
-
Cell cycle, CDKs and cancer: A changing paradigm
-
Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9:153-166
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 153-166
-
-
Malumbres, M.1
Barbacid, M.2
-
25
-
-
38449107684
-
Cell cycle control as a basis for cancer chemoprevention through dietary agents
-
Meeran SM, Katiyar SK (2008) Cell cycle control as a basis for cancer chemoprevention through dietary agents. Front Biosci 13:2191-2202
-
(2008)
Front Biosci
, vol.13
, pp. 2191-2202
-
-
Meeran, S.M.1
Katiyar, S.K.2
-
26
-
-
47149085982
-
P21 and p27: Roles in carcinogenesis and drug resistance
-
Abukhdeir AM, Park BH (2008) P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 10:e19
-
(2008)
Expert Rev Mol Med
, vol.10
-
-
Abukhdeir, A.M.1
Park, B.H.2
-
27
-
-
10844230330
-
Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1
-
Meng LH, Zhang H, Hayward L, Takemura H, Shao RG, Pommier Y (2004) Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res 64: 9086-9092
-
(2004)
Cancer Res
, vol.64
, pp. 9086-9092
-
-
Meng, L.H.1
Zhang, H.2
Hayward, L.3
Takemura, H.4
Shao, R.G.5
Pommier, Y.6
|